How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

28,320 results for

Topical Corticosteroid

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

261. Critical Illness Related Corticosteroids Insufficiency

Study Completion Date : March 1, 2019 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Outcome Measures Go to Primary Outcome Measures : Critical illness related corticosteroid insufficiency [ Time Frame: one year ] Prevalence of CIRCI . most common presentations of CIRCI . the best method of replacment we mesure Random serum cortisol levels and delta cortisol (change in baseline cortisol at 60 minutes after ACTH stimulation using 250 mcg (...) Critical Illness Related Corticosteroids Insufficiency Critical Illness Related Corticosteroids Insufficiency - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Critical Illness Related Corticosteroids

2017 Clinical Trials

262. Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)

Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save (...) this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your

2017 Clinical Trials

263. Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone

Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone Actual Study Start Date : April 17, 2018 Estimated Primary Completion Date : January 2021 Estimated Study Completion Date : October 2021 Resource links provided by the National Library of Medicine related topics: related topics: available for: Arms and Interventions (...) Paris: Lupus erythematosus Systemic Corticosteroid Prednisone Pharmacokinetics Additional relevant MeSH terms: Layout table for MeSH terms Lupus Erythematosus, Systemic Connective Tissue Diseases Autoimmune Diseases Immune System Diseases Prednisone Anti-Inflammatory Agents Glucocorticoids Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Antineoplastic Agents, Hormonal Antineoplastic Agents

2017 Clinical Trials

264. Standardized and Modified Corticosteroid Subacromial Injection for Shoulder Impingement Syndrome

Impingement Syndrome Actual Study Start Date : May 30, 2017 Actual Primary Completion Date : October 1, 2018 Actual Study Completion Date : October 1, 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Modified subacromial injection Intervention procedure: corticosteroid injection into the subacromial bursa and biceps tendon Device for guidance: high-resolution ultrasound Drug: 40 mg triamcinolone acetonide (...) Standardized and Modified Corticosteroid Subacromial Injection for Shoulder Impingement Syndrome Standardized and Modified Corticosteroid Subacromial Injection for Shoulder Impingement Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2017 Clinical Trials

265. Corticosteroids in Alcoholic Hepatitis

Corticosteroids in Alcoholic Hepatitis Corticosteroids in Alcoholic Hepatitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Corticosteroids in Alcoholic Hepatitis The safety and scientific validity (...) Hospital Study Details Study Description Go to Brief Summary: Approximately 50% of patients admitted for severe AH will have spontaneous improvement of liver function before initiation of therapy (ie decrease in mDF between hospital admission and initiation of steroids). These patients have a better prognosis than patients without spontaneous improvement of liver function. It has never been demonstrated that corticosteroids improve survival in severe AH patients with spontaneous improvement of liver

2017 Clinical Trials

266. Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint

Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details

2017 Clinical Trials

267. Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams. (Abstract)

Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams. Superficial fungal infections are among the most commonly managed skin problems by general practitioners. Although evidence shows combination antifungal/corticosteroid topicals are more expensive and less effective than single-agent antifungals, practitioners continue to prescribe combination agents. We examined current prescription trends of 2 combination antifungal/corticosteroid medications, Lotrisone and Mycolog

2017 Journal of Pediatrics

268. Use of intranasal corticosteroids in adenotonsillar hypertrophy. (Abstract)

tubes, and blocks the clearance of nasal mucus. Adenotonsillar hypertrophy and obstructive sleep apnoea are associated with increased expression of various mediators of inflammatory responses in the tonsils, and respond to anti-inflammatory agents such as corticosteroids. Topical nasal steroids most likely affect the anatomical component by decreasing inspiratory upper airway resistance at the nasal, adenoidal or tonsillar levels. Corticosteroids, by their lympholytic or anti-inflammatory effects (...) Use of intranasal corticosteroids in adenotonsillar hypertrophy. This review examined the efficacy of intranasal corticosteroids for improving adenotonsillar hypertrophy.The related literature was searched using PubMed and Proquest Central databases.Adenotonsillar hypertrophy causes mouth breathing, nasal congestion, hyponasal speech, snoring, obstructive sleep apnoea, chronic sinusitis and recurrent otitis media. Adenoidal hypertrophy results in the obstruction of nasal passages and Eustachian

2017 Journal of Laryngology & Otology

269. Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study. (Abstract)

Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study. 4557603 1972 09 13 2018 07 03 0022-3476 81 2 1972 Aug The Journal of pediatrics J. Pediatr. Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study. 366-9 Marks M I MI Chicoine L L Legere G G Hillman E E eng Clinical Trial Controlled Clinical Trial Journal Article Randomized Controlled Trial United States J Pediatr 0375410 0022-3476 0 Hydrocarbons 0 Placebos X4W7ZR7023 (...) Methylprednisolone AIM IM Child, Preschool Clinical Trials as Topic Female Humans Hydrocarbons poisoning Male Methylprednisolone administration & dosage therapeutic use Placebos Pneumonia, Aspiration chemically induced drug therapy 1972 8 1 1972 8 1 0 1 1972 8 1 0 0 ppublish 4557603 S0022-3476(72)80315-9

1972 The Journal of pediatrics Controlled trial quality: uncertain

270. Nonassociation of adrenocorticosteroid therapy and peptic ulcer. (Abstract)

Nonassociation of adrenocorticosteroid therapy and peptic ulcer. 173997 1976 04 02 2009 10 27 0028-4793 294 9 1976 Feb 26 The New England journal of medicine N. Engl. J. Med. Nonassociation of adrenocorticosteroid therapy and peptic ulcer. 473-9 Conn H O HO Blitzer B L BL eng Clinical Trial Journal Article Randomized Controlled Trial Review United States N Engl J Med 0255562 0028-4793 0 Adrenal Cortex Hormones 9002-60-2 Adrenocorticotropic Hormone AIM IM Adrenal Cortex Hormones administration (...) & dosage adverse effects Adrenocorticotropic Hormone adverse effects Clinical Trials as Topic Humans Peptic Ulcer chemically induced epidemiology Peptic Ulcer Hemorrhage chemically induced Research Design 65 1976 2 26 1976 2 26 0 1 1976 2 26 0 0 ppublish 173997 10.1056/NEJM197602262940905

1976 The New England journal of medicine Controlled trial quality: uncertain

271. Comparison of Combination Therapy of Corticosteroids and Bovine Colostrum Versus Corticosteroids and Placebo: Randomized Double Blind Placebo Controlled Trial in Treatment of Severe Alcoholic Hepatitis

Comparison of Combination Therapy of Corticosteroids and Bovine Colostrum Versus Corticosteroids and Placebo: Randomized Double Blind Placebo Controlled Trial in Treatment of Severe Alcoholic Hepatitis Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms (...) by modified Maddrey's Discriminant Function (DF) ≥32, is associated with significant morbidity and mortality.(1,2) Of the various treatment modalities evaluated for treatment of Severe Alcoholic hepatitis, corticosteroids have been the most extensively studied.(1) Five out of 13 randomized controlled trials, and four out of 5 meta-analysis have shown a survival benefit with corticosteroids, especially in patients with DF ≥32 and/ or encephalopathy.(1-4) However, the role of corticosteroids in Severe

2015 Clinical Trials

272. Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis

Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02576249 Recruitment Status : Completed First Posted : October 15, 2015 Results First Posted : July 21, 2017 Last Update Posted : August

2015 Clinical Trials

273. Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases

+ Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases Study Start Date : April 2016 Estimated Primary Completion Date : April 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: bevacizumab + corticosteroids The patient will receive bevacizumab 10 mg/kg IV given on days 1 and 15 of a 28 day cycle for 4 cycles. Once the patient has started (...) Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2015 Clinical Trials

274. Effects of corticosteroids on hyposmia in persistent allergic rhinitis. (Abstract)

Effects of corticosteroids on hyposmia in persistent allergic rhinitis. To asses the effects of two topical nasal corticosteroids sprays on hyposmia in patients with persistent allergic rhinitis.The study was a prospective clinical trial and it included twenty four patients with persistent allergic rhinitis (PER) and hyposmia (H). The patients were divided into two groups depending on the type of corticosteroid topical nasal spray treatment: group A, 200 micrograms dose of mometasone furoate (...) (MF) and group B, 110 micrograms dose of fluticasone furoate (FF) both administered in the morning for 4 weeks. The olfactory function of the patients was evaluated with the extended Test battery "Sniffin' Sticks". The visual analogue scale (VAS) was used for the assessment of hyposmia, nasal discharge. The level of the nasal obstruction, before and after the treatment, was evaluated through the anterior rhinomanometry.The comparisons between the two types of topical corticosteroids showed

2015 Clujul medical (1957) Controlled trial quality: uncertain

275. Medical adherence to topically prescribed corticosteroids and corticosteroid/calcipotriol combinations in the treatment of psoriasis

Medical adherence to topically prescribed corticosteroids and corticosteroid/calcipotriol combinations in the treatment of psoriasis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2016 PROSPERO

276. Safety of topical corticosteroids in pregnancy. (Abstract)

Safety of topical corticosteroids in pregnancy. Topical corticosteroids are the most frequently prescribed dermatological treatment and are frequently used by pregnant women with skin conditions. However, little is known about their safety in pregnancy.To assess the effects of topical corticosteroids on pregnancy outcomes.On 5th May 2009 we searched the Cochrane Skin Group Specialised Register, the Cochrane Pregnancy and Childbirth Group Specialised Register, CENTRAL (The Cochrane Library 2009 (...) , Issue 2), MEDLINE (from 2003), and EMBASE (from 2005). We searched LILACS, CINAHL, British Nursing Index, SCI-EXPANDED, BIOSIS Previews, Conference Papers Index, and Conference Proceedings Citation Index-Science from inception to May 2009. We scanned the bibliographies of the included studies, published reviews, and articles that had cited the included studies. Pharmaceutical companies that have introduced an original topical corticosteroid product were contacted.Randomised controlled trials

2009 Cochrane

277. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Full Text available with Trip Pro

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Non-infectious uveitis is a potentially sight-threatening ocular disorder caused by chronic inflammation and its complications. Therapeutic success is limited by systemic adverse effects associated with long-term corticosteroid and immunomodulator use if topical medication (...) group), nasopharyngitis (16 [17%] and eight [16%] patients, respectively), and headache (17 [15%] patients in each group).Adalimumab significantly lowered the risk of uveitic flare or loss of visual acuity upon corticosteroid withdrawal in patients with inactive, non-infectious intermediate, posterior, or panuveitic uveitis controlled by systemic corticosteroids. No new safety signals were observed and the rate of adverse events was similar between groups. These findings suggest that adalimumab

2016 Lancet Controlled trial quality: predicted high

278. Perioperative Corticosteroid

links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Perioperative Corticosteroid." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Preoperative hormone treatment (C1535921) Concepts Therapeutic or Preventive Procedure ( T061 ) Dutch preoperatieve hormoonbehandeling French Traitement hormonal préopératoire Italian Trattamento ormonale preoperatorio Portuguese (...) Tratamento hormonal pré-operatório Spanish Tratamiento hormonal prequirúrgico Japanese 術前ホルモン療法 , ジュツゼンホルモンリョウホウ Czech Hormonální léčba před operací Hungarian Preoperativ hormonkezelés English Preoperative hormone treatment German praeoperative Hormonbehandlung Derived from the NIH UMLS ( ) Related Topics in Surgery About FPnotebook.com is a rapid access, point-of-care medical reference for primary care and emergency clinicians. Started in 1995, this collection now contains 6656 interlinked topic pages

2018 FP Notebook

279. Injectable Corticosteroid

(Decadron) (Celestone Soluspan) Relative Potency: 25 (0.6 mg) Supplied: 4 mg/ml, 6 mg/ml, 8 mg/ml Dosing Tendon Sheath and bursas: 1.5-3.0 mg Small Joints: 0.8-1.0 mg Large Joints: 2-4 mg V. Reference Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Injectable Corticosteroid." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Related Topics in Pharmacology (...) Injectable Corticosteroid Injectable Corticosteroid Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Injectable Corticosteroid

2018 FP Notebook

280. Inhaled Corticosteroid

Inhaled Corticosteroid Inhaled Corticosteroid Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Inhaled Corticosteroid Inhaled (...) Corticosteroid Aka: Inhaled Corticosteroid , Inhaled Steroid , Azmacort , Beclovent , AeroBid , Flovent , Pulmicort , Vanceril From Related Chapters II. Indications: Most important agent in Asthma Management III. Efficacy Inhaled Corticosteroids reduce related death Mortality risk decreases with steroid s/year Benefits in and persist for >5 years Costs HFA s are non-generic and costly Older CFC s are no longer available IV. General For dosing below, adult is age 12 or older V. Preparation: Triamcinolone

2018 FP Notebook

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>